{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30279553", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "17"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "02"}], "Language": ["eng"], "ELocationID": ["14644", "10.1038/s41598-018-32953-7"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "8", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Oct", "Day": "02"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Arrowtail RNA for Ligand Display on Ginger Exosome-like Nanovesicles to Systemic Deliver siRNA for Cancer Suppression.", "Pagination": {"StartPage": "14644", "MedlinePgn": "14644"}, "Abstract": {"AbstractText": ["Exosomes have shown increasing potential as delivery vesicles for therapy, but challenges like cost/yield, drug payload, and targeting specificity still exist. Plant derived exosome-like nanoparticles have been reported as a promising substitution and exhibit biocompatibility through oral, intranasal administration; however, systemic delivery of siRNA by exosome-like nanoparticles directly isolated from plants has not been reported. Recently, we reported the control of RNA orientation to decorate human derived exosome with cell targeting ligands for specific delivery of siRNA to tumors. Here, we expand to the application of arrowtail RNA nanoparticles for displaying ligands on ginger derived exosome-like nanovesicles (GDENs) for siRNA delivery and tumor inhibition through IV administration. Cushion ultracentrifugation coupled with equilibrium density gradient ultracentrifugation were used for purifying GDENs that displayed size, density, and morphology similar to human derived exosomes. Folic acid (FA), as a ligand, was displayed on the surface of GDENs for targeted delivery of survivin siRNA to KB cancer models. In vitro gene knockdown efficacy by FA-3WJ/GDENs/siRNA complex was comparable to transfection. We observed inhibition of tumor growth on a xenograft model by intravenous administration, which reveals the potential of GDENs as an economic delivery system for siRNA."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, Division of Pharmaceutics and Pharmaceutical Chemistry, College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, NCI Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA."}], "LastName": "Li", "ForeName": "Zhefeng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, Division of Pharmaceutics and Pharmaceutical Chemistry, College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, NCI Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA."}], "LastName": "Wang", "ForeName": "Hongzhi", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, Division of Pharmaceutics and Pharmaceutical Chemistry, College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, NCI Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA."}], "LastName": "Yin", "ForeName": "Hongran", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Chemistry Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA."}], "LastName": "Bennett", "ForeName": "Chad", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "James Brown Cancer Center, Department of Microbiology & Immunology, University of Louisville, Louisville, KY, USA."}], "LastName": "Zhang", "ForeName": "Huang-Ge", "Initials": "HG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, Division of Pharmaceutics and Pharmaceutical Chemistry, College of Medicine, Dorothy M. Davis Heart and Lung Research Institute, NCI Comprehensive Cancer Center, The Ohio State University, Columbus, OH, 43210, USA. guo.1091@osu.edu."}], "LastName": "Guo", "ForeName": "Peixuan", "Initials": "P"}], "GrantList": [{"GrantID": "UH3 TR000875", "Acronym": "TR", "Agency": "NCATS NIH HHS", "Country": "United States"}, {"GrantID": "U01 CA207946", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA186100", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P30 CA016058", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drug Carriers"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Small Interfering"}, {"RegistryNumber": "0", "NameOfSubstance": "Survivin"}, {"RegistryNumber": "935E97BOY8", "NameOfSubstance": "Folic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drug Carriers"}, {"QualifierName": ["chemistry"], "DescriptorName": "Exosomes"}, {"QualifierName": ["chemistry"], "DescriptorName": "Folic Acid"}, {"QualifierName": ["metabolism"], "DescriptorName": "Zingiber officinale"}, {"QualifierName": [], "DescriptorName": "HEK293 Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nanoparticles"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "RNA, Small Interfering"}, {"QualifierName": ["genetics"], "DescriptorName": "Survivin"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}], "CoiStatement": "P.G. is the consultant of Oxford Nanopore Technologies, Inc; the cofounder of Shenzhen P&Z Bio-medical Co. Ltd and its subsidiary US P&Z Biological Technology LLC, as well as cofounder of ExonanoRNA, LLC and its subsidiary ExonanoRNA (Foshan) Biomedicine Co., LTD."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Varez-Erviti L, et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29:341\u2013345. doi: 10.1038/nbt.1807.", "ArticleIdList": ["10.1038/nbt.1807", "21423189"]}, {"Citation": "Batrakova, E. V. & Kim, M. S., Using exosomes, naturally-equipped nanocarriers, for drug delivery. J. Control Release (2015).", "ArticleIdList": ["PMC4656109", "26241750"]}, {"Citation": "El-Andaloussi S, Lakhal S, Mager I, Wood MJ. Exosomes for targeted siRNA delivery across biological barriers. Adv. Drug Deliv. Rev. 2013;65:391\u2013397. doi: 10.1016/j.addr.2012.08.008.", "ArticleIdList": ["10.1016/j.addr.2012.08.008", "22921840"]}, {"Citation": "Sun D, et al. Exosomes are endogenous nanoparticles that can deliver biological information between cells. Adv. Drug Deliv. Rev. 2013;65:342\u2013347. doi: 10.1016/j.addr.2012.07.002.", "ArticleIdList": ["10.1016/j.addr.2012.07.002", "22776312"]}, {"Citation": "Pi F, et al. Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression. Nat Nanotechnol. 2018;13:82\u201389. doi: 10.1038/s41565-017-0012-z.", "ArticleIdList": ["10.1038/s41565-017-0012-z", "PMC5762263", "29230043"]}, {"Citation": "Zhang D, et al. Enrichment of selective miRNAs in exosomes and delivery of exosomal miRNAs in vitro and in vivo. Am. J Physiol Lung Cell Mol Physiol. 2017;312:L110\u2013L121. doi: 10.1152/ajplung.00423.2016.", "ArticleIdList": ["10.1152/ajplung.00423.2016", "PMC5283929", "27881406"]}, {"Citation": "Dreyer F, Baur A. Biogenesis and Functions of Exosomes and Extracellular Vesicles. Methods Mol Biol. 2016;1448:201\u2013216. doi: 10.1007/978-1-4939-3753-0_15.", "ArticleIdList": ["10.1007/978-1-4939-3753-0_15", "27317183"]}, {"Citation": "Valadi H, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654\u2013659. doi: 10.1038/ncb1596.", "ArticleIdList": ["10.1038/ncb1596", "17486113"]}, {"Citation": "Shtam TA, et al. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun. Signal. 2013;11:88. doi: 10.1186/1478-811X-11-88.", "ArticleIdList": ["10.1186/1478-811X-11-88", "PMC3895799", "24245560"]}, {"Citation": "Li P, et al. Progress in Exosome Isolation Techniques. Theranostics. 2017;7:789\u2013804. doi: 10.7150/thno.18133.", "ArticleIdList": ["10.7150/thno.18133", "PMC5327650", "28255367"]}, {"Citation": "Franzen CA, et al. Urinary Exosomes: The Potential for Biomarker Utility, Intercellular Signaling and Therapeutics in Urological Malignancy. J Urol. 2016;195:1331\u20131339. doi: 10.1016/j.juro.2015.08.115.", "ArticleIdList": ["10.1016/j.juro.2015.08.115", "26714199"]}, {"Citation": "Munagala R, Aqil F, Jeyabalan J, Gupta RC. Bovine milk-derived exosomes for drug delivery. Cancer Lett. 2016;371:48\u201361. doi: 10.1016/j.canlet.2015.10.020.", "ArticleIdList": ["10.1016/j.canlet.2015.10.020", "PMC4706492", "26604130"]}, {"Citation": "Zhang M, Viennois E, Xu C, Merlin D. Plant derived edible nanoparticles as a new therapeutic approach against diseases. Tissue Barriers. 2016;4:e1134415. doi: 10.1080/21688370.2015.1134415.", "ArticleIdList": ["10.1080/21688370.2015.1134415", "PMC4910829", "27358751"]}, {"Citation": "Quesenberry PJ, et al. Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium. J Extracell. Vesicles. 2015;4:27575. doi: 10.3402/jev.v4.27575.", "ArticleIdList": ["10.3402/jev.v4.27575", "PMC4553260", "26320942"]}, {"Citation": "Wang B, et al. Targeted drug delivery to intestinal macrophages by bioactive nanovesicles released from grapefruit. Mol Ther. 2014;22:522\u2013534. doi: 10.1038/mt.2013.190.", "ArticleIdList": ["10.1038/mt.2013.190", "PMC3944329", "23939022"]}, {"Citation": "Ju S, et al. Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. Mol Ther. 2013;21:1345\u20131357. doi: 10.1038/mt.2013.64.", "ArticleIdList": ["10.1038/mt.2013.64", "PMC3702113", "23752315"]}, {"Citation": "Zhang M, et al. Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials. 2016;101:321\u2013340. doi: 10.1016/j.biomaterials.2016.06.018.", "ArticleIdList": ["10.1016/j.biomaterials.2016.06.018", "PMC4921206", "27318094"]}, {"Citation": "Zhuang X, et al. Ginger-derived nanoparticles protect against alcohol-induced liver damage. J Extracell. Vesicles. 2015;4:28713. doi: 10.3402/jev.v4.28713.", "ArticleIdList": ["10.3402/jev.v4.28713", "PMC4662062", "26610593"]}, {"Citation": "Regente M, et al. Vesicular fractions of sunflower apoplastic fluids are associated with potential exosome marker proteins. FEBS Lett. 2009;583:3363\u20133366. doi: 10.1016/j.febslet.2009.09.041.", "ArticleIdList": ["10.1016/j.febslet.2009.09.041", "19796642"]}, {"Citation": "Mu J, et al. Interspecies communication between plant and mouse gut host cells through edible plant derived exosome-like nanoparticles. Mol Nutr. Food Res. 2014;58:1561\u20131573. doi: 10.1002/mnfr.201300729.", "ArticleIdList": ["10.1002/mnfr.201300729", "PMC4851829", "24842810"]}, {"Citation": "Deng Z, et al. Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase. Mol Ther. 2017;25:1641\u20131654. doi: 10.1016/j.ymthe.2017.01.025.", "ArticleIdList": ["10.1016/j.ymthe.2017.01.025", "PMC5498816", "28274798"]}, {"Citation": "Wang Q, et al. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun. 2013;4:1867. doi: 10.1038/ncomms2886.", "ArticleIdList": ["10.1038/ncomms2886", "PMC4396627", "23695661"]}, {"Citation": "Teng Y, et al. Grapefruit-derived nanovectors deliver miR-18a for treatment of liver metastasis of colon cancer by induction of M1 macrophages. Oncotarget. 2016;7:25683\u201325697.", "ArticleIdList": ["PMC5041936", "27028860"]}, {"Citation": "Wang Q, et al. Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites. Cancer Res. 2015;75:2520\u20132529. doi: 10.1158/0008-5472.CAN-14-3095.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-3095", "PMC4470740", "25883092"]}, {"Citation": "Guo P. The emerging field of RNA nanotechnology. Nature Nanotechnology. 2010;5:833\u2013842. doi: 10.1038/nnano.2010.231.", "ArticleIdList": ["10.1038/nnano.2010.231", "PMC3149862", "21102465"]}, {"Citation": "Shu D, et al. Thermodynamically stable RNA three-way junctions for constructing multifuntional nanoparticles for delivery of therapeutics. Nature Nanotechnology. 2011;6:658\u2013667. doi: 10.1038/nnano.2011.105.", "ArticleIdList": ["10.1038/nnano.2011.105", "PMC3189281", "21909084"]}, {"Citation": "Shu Y, et al. Fabrication of 14 Different RNA Nanoparticles for Specific Tumor Targeting without Accumulation in Normal Organs. RNA. 2013;19:766\u2013777. doi: 10.1261/rna.037002.112.", "ArticleIdList": ["10.1261/rna.037002.112", "PMC3683911", "23604636"]}, {"Citation": "Xu C, et al. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy. Cancer Lett. 2018;414:57\u201370. doi: 10.1016/j.canlet.2017.09.043.", "ArticleIdList": ["10.1016/j.canlet.2017.09.043", "PMC5844565", "28987384"]}, {"Citation": "Jasinski D, Haque F, Binzel DW, Guo P. Advancement of the Emerging Field of RNA Nanotechnology. ACS Nano. 2017;11:1142\u20131164. doi: 10.1021/acsnano.6b05737.", "ArticleIdList": ["10.1021/acsnano.6b05737", "PMC5333189", "28045501"]}, {"Citation": "Guo P, Erickson S, Anderson D. A small viral RNA is required for in vitro packaging of bacteriophage phi29 DNA. Science. 1987;236:690\u2013694. doi: 10.1126/science.3107124.", "ArticleIdList": ["10.1126/science.3107124", "3107124"]}, {"Citation": "Guo P, et al. Inter-RNA interaction of phage phi29 pRNA to form a hexameric complex for viral DNA transportation. Mol. Cell. 1998;2:149\u2013155. doi: 10.1016/S1097-2765(00)80124-0.", "ArticleIdList": ["10.1016/S1097-2765(00)80124-0", "9702202"]}, {"Citation": "Shu D, et al. Bottom-up assembly of RNA arrays and superstructures as potential parts in nanotechnology. Nano Lett. 2004;4:1717\u20131723. doi: 10.1021/nl0494497.", "ArticleIdList": ["10.1021/nl0494497", "PMC3010238", "21171616"]}, {"Citation": "Shu Y, et al. Stable RNA nanoparticles as potential new generation drugs for cancer therapy. Adv. Drug Deliv. Rev. 2014;66C:74\u201389. doi: 10.1016/j.addr.2013.11.006.", "ArticleIdList": ["10.1016/j.addr.2013.11.006", "PMC3955949", "24270010"]}, {"Citation": "Li H, et al. RNA as a stable polymer to build controllable and defined nanostructures for material and biomedical applications. Nano Today. 2015;10:631\u2013655. doi: 10.1016/j.nantod.2015.09.003.", "ArticleIdList": ["10.1016/j.nantod.2015.09.003", "PMC4707685", "26770259"]}, {"Citation": "Jasinski D, Schwartz C, Haque F, Guo P. Large Scale Purification of RNA Nanoparticles by Preparative Ultracentrifugation. Methods in Molecular Biology. 2015;1297:67\u201382. doi: 10.1007/978-1-4939-2562-9_5.", "ArticleIdList": ["10.1007/978-1-4939-2562-9_5", "25895996"]}, {"Citation": "Szatanek R, Baran J, Siedlar M, Baj-Krzyworzeka M. Isolation of extracellular vesicles: Determining the correct approach (Review) Int. J Mol Med. 2015;36:11\u201317. doi: 10.3892/ijmm.2015.2194.", "ArticleIdList": ["10.3892/ijmm.2015.2194", "PMC4494580", "25902369"]}, {"Citation": "Linares R, et al. High-speed centrifugation induces aggregation of extracellular vesicles. J Extracell. Vesicles. 2015;4:29509. doi: 10.3402/jev.v4.29509.", "ArticleIdList": ["10.3402/jev.v4.29509", "PMC4689953", "26700615"]}, {"Citation": "Garg H, et al. Survivin: a unique target for tumor therapy. Cancer Cell Int. 2016;16:49. doi: 10.1186/s12935-016-0326-1.", "ArticleIdList": ["10.1186/s12935-016-0326-1", "PMC4917988", "27340370"]}, {"Citation": "Deniz AA, et al. Single-pair fluorescence resonance energy transfer on freely diffusing molecules: observation of Forster distance dependence and subpopulations. Proc. Natl. Acad. Sci. USA. 1999;96:3670\u20133675. doi: 10.1073/pnas.96.7.3670.", "ArticleIdList": ["10.1073/pnas.96.7.3670", "PMC22352", "10097095"]}, {"Citation": "Norman DG, Grainger RJ, Uhrin D, Lilley DM. Location of cyanine-3 on double-stranded DNA: importance for fluorescence resonance energy transfer studies. Biochemistry. 2000;39:6317\u20136324. doi: 10.1021/bi992944a.", "ArticleIdList": ["10.1021/bi992944a", "10828944"]}, {"Citation": "Shu D, et al. Dual-channel single-molecule fluorescence resonance energy transfer to establish distance parameters for RNA nanoparticles. ACS Nano. 2010;4:6843\u20136853. doi: 10.1021/nn1014853.", "ArticleIdList": ["10.1021/nn1014853", "PMC2990273", "20954698"]}, {"Citation": "Zhang, H., Shu, D., Browne, M. & Guo, P., Approaches for stoichiometry and distance determination of nanometer bio-complex by dual-channel single molecule imaging. IEEE/NIH Life Science Systems and Applications Workshop 124\u2013127 (2009).", "ArticleIdList": ["PMC2871710", "20485472"]}, {"Citation": "Zhang H, et al. Crystal Structure of 3WJ Core Revealing Divalent Ion-promoted Thermostability and Assembly of the Phi29 Hexameric Motor pRNA. RNA. 2013;19:1226\u20131237. doi: 10.1261/rna.037077.112.", "ArticleIdList": ["10.1261/rna.037077.112", "PMC3753930", "23884902"]}, {"Citation": "Paulos CM, et al. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Mol Pharmacol. 2004;66:1406\u20131414. doi: 10.1124/mol.104.003723.", "ArticleIdList": ["10.1124/mol.104.003723", "15371560"]}, {"Citation": "Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am. J Clin. Nutr. 2007;86:271\u2013273. doi: 10.1093/ajcn/86.2.271.", "ArticleIdList": ["10.1093/ajcn/86.2.271", "17684194"]}, {"Citation": "Ahmed T, et al. Effect of folic acid on human trophoblast health and function in vitro. Placenta. 2016;37:7\u201315. doi: 10.1016/j.placenta.2015.11.012.", "ArticleIdList": ["10.1016/j.placenta.2015.11.012", "26748157"]}, {"Citation": "Zhang M, et al. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine (Lond) 2017;12:1927\u20131943. doi: 10.2217/nnm-2017-0196.", "ArticleIdList": ["10.2217/nnm-2017-0196", "PMC5827822", "28665164"]}, {"Citation": "Thery, C., Amigorena, S., Raposo, G. & Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol Chapter 3 Unit (2006).", "ArticleIdList": ["18228490"]}, {"Citation": "Shu Y, Shu D, Haque F, Guo P. Fabrication of pRNA nanoparticles to deliver therapeutic RNAs and bioactive compounds into tumor cells. Nat. Protoc. 2013;8:1635\u20131659. doi: 10.1038/nprot.2013.097.", "ArticleIdList": ["10.1038/nprot.2013.097", "PMC3883045", "23928498"]}]}], "History": [{"Year": "2018", "Month": "5", "Day": "14"}, {"Year": "2018", "Month": "9", "Day": "6"}, {"Year": "2018", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["30279553", "PMC6168523", "10.1038/s41598-018-32953-7", "10.1038/s41598-018-32953-7"]}}]}